Saxagliptin recalls

Saxagliptin products have been recalled 2 times, most recently on 16 Apr 2025. The recalling company is usually Glenmark Pharmaceuticals Inc., U. The most common reason is manufacturing (cgmp) deviations.

Total recalls2since 2025

Last 12 months0reported

Class I00% of total

Ongoing2latest 16 Apr 2025

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 2Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why saxagliptin is recalled

Manufacturing (CGMP) Deviations2100%

Companies

Glenmark Pharmaceuticals Inc., U2100%

By year

20252100%

Ongoing saxagliptin recalls

2 active

Reported	Class	Recall	Company	Reason	Where
16 Apr 2025Drug	CLASS II	Saxagliptin Tablets 5mg, a) recalled by Glenmark PharmaceuticalsSaxagliptin	Glenmark Pharmaceuticals Inc., U	Manufacturing (CGMP) Deviations	Nationwide
16 Apr 2025Drug	CLASS II	Saxagliptin Tablets, USP, 5mg, a) recalled by Glenmark PharmaceuticalsSaxagliptin	Glenmark Pharmaceuticals Inc., U	Manufacturing (CGMP) Deviations	Nationwide

All saxagliptin recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
16 Apr 2025Drug	CLASS II	Saxagliptin Tablets 5mg, a) recalled by Glenmark PharmaceuticalsSaxagliptin	Glenmark Pharmaceuticals Inc., U	Manufacturing (CGMP) Deviations	Nationwide
16 Apr 2025Drug	CLASS II	Saxagliptin Tablets, USP, 5mg, a) recalled by Glenmark PharmaceuticalsSaxagliptin	Glenmark Pharmaceuticals Inc., U	Manufacturing (CGMP) Deviations	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.